Emmanuelle Papuchon
Overview
Explore the profile of Emmanuelle Papuchon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goutaudier V, Danger R, Catar R, Racape M, Philippe A, Elias M, et al.
Kidney Int
. 2024 Aug;
106(5):943-960.
PMID: 39197587
Non-invasive biomarkers are promising tools for improving kidney allograft rejection monitoring, but their clinical adoption requires more evidence in specifically designed studies. To address this unmet need, we designed the...
2.
Goutaudier V, Sablik M, Racape M, Rousseau O, Audry B, Kamar N, et al.
Eur J Epidemiol
. 2024 Apr;
39(5):549-564.
PMID: 38625480
There is an unmet need for robust and clinically validated biomarkers of kidney allograft rejection. Here we present the KTD-Innov study (ClinicalTrials.gov, NCT03582436), an unselected deeply phenotyped cohort of kidney...
3.
Danger R, Le Berre L, Cadoux M, Kerleau C, Papuchon E, Mai H, et al.
Kidney Int
. 2023 Mar;
103(6):1167-1179.
PMID: 36990211
We previously established a six-gene-based blood score associated with operational tolerance in kidney transplantation which was decreased in patients developing anti-HLA donor-specific antibodies (DSA). Herein, we aimed to confirm that...
4.
De Carvalho H, Letellier T, Karakachoff M, Desvaux G, Caillon H, Papuchon E, et al.
J Nephrol
. 2021 Apr;
34(4):991-998.
PMID: 33826113
Aim: Our objective was to describe the impact of hyponatremia on the outcomes of COVID-19 patients [outcomes selected: intensive care unit (ICU) admission, mechanical ventilation or death]. Methods: Two groups...
5.
Sebille V, Hardouin J, Giral M, Bonnaud-Antignac A, Tessier P, Papuchon E, et al.
BMC Nephrol
. 2016 Jan;
17:11.
PMID: 26785745
Background: Treatment of end stage renal disease has an impact on patients' physical and psychological health, including quality of life (QoL). Nowadays, it is known that reducing the dialysis period...
6.
Chapal M, Foucher Y, Marguerite M, Neau K, Papuchon E, Daguin P, et al.
Trials
. 2015 Jun;
16:282.
PMID: 26099226
Background: In kidney transplantation, the use of Anti-Thymocyte Globulins (ATG) as induction therapy has been described as a possible treatment for reducing the prevalence of Delayed Graft Function (DGF). ATG...
7.
Foucher Y, Meurette A, Daguin P, Bonnaud-Antignac A, Hardouin J, Chailan S, et al.
BMC Nephrol
. 2015 Jan;
16:6.
PMID: 25631635
Background: Numerous well-established clinical parameters are taken into consideration for the follow-up adaptation of kidney transplant recipients, but there are important disparities between countries, centres and clinicians. Therefore, novel scoring...